1.Antiviral Agents.
Journal of the Korean Medical Association 1998;41(3):301-311
No abstract available.
Antiviral Agents*
2.Two Cases of Granulation Tissues Arising on the Periungual Area.
Ji Youn SONG ; Ji Hyun LIM ; Jung Hoon LEE ; Tae Yoon KIM ; Jun Young LEE
Korean Journal of Dermatology 2003;41(8):1088-1090
Granulation tissues may arise around the nail in response to trauma to the nail or to ingrowing nails. Drugs, such as retinoids or antiviral agents may be the cause of granulation tissue of the whole body or nails. We experienced two cases of granulation tissue developed on the proximal nail folds and subungual area after putting on tight cast and Korean traditional socks respectively. We reported the cases with review of the literature.
Antiviral Agents
;
Granulation Tissue*
;
Retinoids
3.Treatment of Chronic Hepatitis C Patients Who Do Not Respond to Direct Acting Antivirals.
The Korean Journal of Gastroenterology 2017;70(2):111-113
No abstract available.
Antiviral Agents*
;
Hepatitis C, Chronic*
;
Hepatitis, Chronic*
4.New antiviral agents for treatment of chronic hepatitis B.
Korean Journal of Medicine 2005;69(3):338-342
No abstract available.
Antiviral Agents*
;
Hepatitis B, Chronic*
;
Hepatitis, Chronic*
5.Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice.
Gut and Liver 2018;12(6):609-610
No abstract available.
Antiviral Agents*
;
Coinfection*
;
Hepatitis C*
;
Hepatitis*
;
Humans
8.Antiviral Agents Against Influenza Viruses.
Sehee PARK ; Jin Il KIM ; Man Seong PARK
Journal of Bacteriology and Virology 2012;42(4):284-293
In annual epidemics and occasional pandemics, influenza viruses cause acute respiratory illnesses in infected humans. Vaccines and antiviral drugs are two main arsenals available for a fight against influenza viruses. However, vaccines often exhibit a limited efficacy in high risk populations, and antiviral drugs are always concerned for mutations, which confer viral resistance. Here we review current advances and knowledge in relation to the usage of antiviral drugs as a prophylactic or therapeutic and the mechanism of resistant variants mainly against the neuraminidase inhibitors. Comprehensive understanding of the resistant mechanism will pave a road for developing new antivirals and/or finding medical or natural alternatives inducing less frequent resistance, and application of combination therapy using two or three different kinds of antivirals can suggest a useful medical intervention against both of seasonal and highly pathogenic influenza viruses including resistant variants. In this review, we provide insights of antiviral drugs for the control and prevention of influenza viruses.
Antiviral Agents
;
Humans
;
Influenza, Human
;
Neuraminidase
;
Orthomyxoviridae
;
Pandemics
;
Seasons
;
Vaccines
10.Dose and Treatment Duration of Regimen.
The Korean Journal of Hepatology 2005;11(1):13-16
No abstract available.
Antiviral Agents/administration & dosage
;
Hepatitis B, Chronic/*drug therapy
;
Humans
Result Analysis
Print
Save
E-mail